FDA Commissioner Margaret Hamburg says FDA is still honing its medical device regulatory process so that it strikes a balance between patient safety and industry's desire to market their products. But she says she is not sure the U.S. or the Europeans have gotten that balance right yet.
Speaking during what was probably her last public appearance at the National Press Club in Washington, D.C., Hamburg told journalists that she has been fascinated during her tenure by the different responses from stakeholders about whether the agency's regulatory oversight of medical devices is too lax or two restricting. After almost six years in the post, Hamburg announced in February she was stepping down
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
